rs794727741
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM1PM2PP2PP3_ModeratePP5_Very_Strong
The NM_172107.4(KCNQ2):c.701C>T(p.Thr234Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_172107.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 29
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 29
ClinVar
Submissions by phenotype
not provided Pathogenic:1Uncertain:1
- -
Reported in an individual with seizures and developmental delay, though parental segregation was not included (PMID: 29056246); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This substitution is predicted to be within the transmembrane segment S5; Missense variants in this gene are often considered pathogenic (HGMD); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25818041, 29720203, 29056246) -
Early infantile epileptic encephalopathy with suppression bursts Pathogenic:1
This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 234 of the KCNQ2 protein (p.Thr234Ile). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of epilepsy (PMID: 29056246, 29720203; Invitae). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 197892). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KCNQ2 protein function with a positive predictive value of 95%. This variant disrupts the p.Thr234 amino acid residue in KCNQ2. Other variant(s) that disrupt this residue have been observed in individuals with KCNQ2-related conditions (PMID: 25818041; Invitae), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. -
Developmental and epileptic encephalopathy, 7 Pathogenic:1
The c.701C>T, p.Thr234Ile, variant found is located in exon 5 of the KCNQ2 gene. This variant is reported in ClinVar (rs794727741) classified as pathogenic and in this same database it is reported de novo with no family history of the pathology (ClinVar: VCV000197892.16) (PMID:29056246) (PS2). The variant is located in a functional domain of the protein (PM1). Other variants in the same amino acid position (p.Thr234Pro, p.Thr234Ala) have been described and classified as pathogenic (PMID:25818041; PMID:29720203) (PM5). The variant found is not present in population databases such as GnomAD, ExAc or 1000 genomes (PM2_Supporting). Missense variants are a frequent cause of pathogenicity in this gene, with 362 pathogenic variants described and only 25 benign (PP2). Bioinformatics predictors classify this variant as deleted (PP3). A 6-year-old patient with intellectual disability presented seizures from the second day of life that were refractory to treatment. -
Seizure Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at